Updates from the Exchange

The Male Contraceptive Initiative (MCI) has announced three new funding opportunities: the David Sokal Innovation Awards, the Discovery & Development Awards,...

The NIH and NICHD have three new funding opportunity announcements pertaining to contraceptive development. Brief descriptions of each...

On July 11, the U.S. Food and Drug Administration (FDA) issued new draft guidance entitled “Establishing Effectiveness and Safety for...

Through July 31, 2019, the Global Health Technologies Coalition will be accepting nominations for the 2019 Innovating for Impact Awards...

MCI’s 2019 FRA is open for submission. This funding will support research in reversible, non-hormonal male contraceptive discovery and...

The Demographic and Health Surveys (DHS) Program is currently soliciting feedback on its model questionnaires, optional modules, and bio...

The NICHD has issued a Request for Information (RFI) to solicit feedback on its new strategic plan. NICHD is seeking input from a variety...

The National Institutes of Health has released a new funding solicitation to support the development of novel nonsteroidal contraceptive...

Applications for Ferring Pharmaceuticals’ Innovation Grants Program are open until June 11th. Non-renewable awards of $50,000 to $100,000..

The Male Contraception Initiative (MCI) will fund four research teams working to develop a new reversible non-hormonal birth control pill...

Eunice Kennedy Shriver Natl. Institute of Child Health and Human Development is accepting Small Business Innovation Research applications...

Calls for abstracts and panels have been announced for three upcoming conferences of interest to contraceptive researchers. Including...